Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Cancer. 2018 Apr 6;124(16):3293–3306. doi: 10.1002/cncr.31367

Table 3.

Component and Global Assessment of Study Quality for Studies with Published Results

First Author Intervention Selection Bias Study Design Confounders Blinding Data Collection Withdrawals and Dropouts Global Rating
Loy18 EBRT Bundle 3 2 3 2 2 3 3
Newcomer19 UHC Bundle Pilot 2 2 1 2 2 3 2
Butcher20 Aetna Cancer-Specific ACO 3 2 3 2 3 3 3
Colla21 PGPD Project 2 2 1 2 1 3 2
Herrel22 MSSP ACO Analysis 2 2 1 2 1 3 2
Kohler26 NC Medicaid PCMH 2 2 1 2 1 3 2
Goyal27 NC Medicaid PCMH 2 2 1 2 1 2 2
Kuntz28 Michigan Oncology Medical Home 2 2 3 2 3 3 3
Reinke29 CareFirst 3 2 3 2 3 3 3
Shah30 National PCMH* 2 3 3 2 3 3 3
Sprandio12 CMOH 2 2 3 2 3 3 3
Waters32 COME HOME 2 2 3 2 3 3 3
Sharma34 The Diabetes Oncology Program× 2 2 3 2 2 2 2

Scores of 1, 2, and 3 correspond to strong, moderate, and weak quality, respectively, using the Effective Public Health Practice Project Quality Assessment Tool for Quantitative Studies.13

Abbreviations: EBRT = external beam radiation therapy; UHC = United Healthcare; ACO = Accountable care organization; PGPD = Physician Group Practice Demonstration; MSSP = Medicare Shared Savings Program; NC = North Carolina; PCMH = Patient Centered Medical Home; CMOH = Consultants in Medical Oncology and Hematology; COME HOME = Community Oncology Medical Home.

*

Abstract Only

×

Graduate School Dissertation Thesis